Wilfred R Pigeon1, Jennifer Funderburk2, Todd M Bishop3, Hugh F Crean4. 1. Center of Excellence for Suicide Prevention, Canandaigua VA Medical Center, USA; Center for Integrated Healthcare, Syracuse VA Medical Center, USA; University of Rochester Medical Center, Department of Psychiatry, USA. Electronic address: Wilfred.Pigeon2@va.gov. 2. Center for Integrated Healthcare, Syracuse VA Medical Center, USA; University of Rochester Medical Center, Department of Psychiatry, USA; Syracuse University, USA. 3. Center of Excellence for Suicide Prevention, Canandaigua VA Medical Center, USA; Center for Integrated Healthcare, Syracuse VA Medical Center, USA; University of Rochester Medical Center, Department of Psychiatry, USA. 4. Center of Excellence for Suicide Prevention, Canandaigua VA Medical Center, USA; University of Rochester School of Nursing, USA.
Abstract
BACKGROUND: Depression and insomnia are treatable, often co-occur and are common among primary care patients. Treatments designed for primary care must be brief, effective and ideally have the potential to address multiple symptoms. A brief form of cognitive behavioral therapy for insomnia (CBT-I) was piloted among depressed primary care patients with insomnia some of whom endorsed suicidal ideation. METHODS:Veterans Affairs primary care patients were randomized to either CBT-I or sleep hygiene. CBT-I consisted of two, 20-40min in-person sessions and two 15-20min telephone sessions; SH consisted of one in-person and one telephone session. Participants were assessed at baseline, post-treatment, and a 3 month follow-up. RESULTS: Compared to SH (n=14), brief CBT-I (n=13) had large effects on insomnia severity, sleep efficiency, number of awakenings, and time awake after sleep onset with between group effect sizes ranging from .75 to 1.09 at post-treatment and .66-.89 at follow-up, though significance was not maintained at follow-up. Although both groups experienced significant reductions in depression severity, statistically significant group by time interactions were not observed for depression. LIMITATIONS: Notable limitations include the small sample size, having excluded patients with the most severe suicide risk, and the absence of objective testing to detect presence of sleep disorders other than insomnia. CONCLUSIONS: The effects observed for insomnia outcomes, corroborate support for using CBT-I in depressed patients and extend this support to a brief from of CBT-I structured for delivery in primary care. Whether a brief form of CBT-I delivered to patients in primary care who endorse suicidal ideation would have a significant effect on depressive symptoms and/or suicidal ideation remains to be tested in a fully powered trial.
RCT Entities:
BACKGROUND:Depression and insomnia are treatable, often co-occur and are common among primary care patients. Treatments designed for primary care must be brief, effective and ideally have the potential to address multiple symptoms. A brief form of cognitive behavioral therapy for insomnia (CBT-I) was piloted among depressed primary care patients with insomnia some of whom endorsed suicidal ideation. METHODS: Veterans Affairs primary care patients were randomized to either CBT-I or sleep hygiene. CBT-I consisted of two, 20-40min in-person sessions and two 15-20min telephone sessions; SH consisted of one in-person and one telephone session. Participants were assessed at baseline, post-treatment, and a 3 month follow-up. RESULTS: Compared to SH (n=14), brief CBT-I (n=13) had large effects on insomnia severity, sleep efficiency, number of awakenings, and time awake after sleep onset with between group effect sizes ranging from .75 to 1.09 at post-treatment and .66-.89 at follow-up, though significance was not maintained at follow-up. Although both groups experienced significant reductions in depression severity, statistically significant group by time interactions were not observed for depression. LIMITATIONS: Notable limitations include the small sample size, having excluded patients with the most severe suicide risk, and the absence of objective testing to detect presence of sleep disorders other than insomnia. CONCLUSIONS: The effects observed for insomnia outcomes, corroborate support for using CBT-I in depressedpatients and extend this support to a brief from of CBT-I structured for delivery in primary care. Whether a brief form of CBT-I delivered to patients in primary care who endorse suicidal ideation would have a significant effect on depressive symptoms and/or suicidal ideation remains to be tested in a fully powered trial.
Authors: María José Membrive-Jiménez; José Luis Gómez-Urquiza; Nora Suleiman-Martos; Almudena Velando-Soriano; Tania Ariza; Emilia Inmaculada De la Fuente-Solana; Guillermo A Cañadas-De la Fuente Journal: Healthcare (Basel) Date: 2022-05-21
Authors: Jack D Edinger; J Todd Arnedt; Suzanne M Bertisch; Colleen E Carney; John J Harrington; Kenneth L Lichstein; Michael J Sateia; Wendy M Troxel; Eric S Zhou; Uzma Kazmi; Jonathan L Heald; Jennifer L Martin Journal: J Clin Sleep Med Date: 2021-02-01 Impact factor: 4.062
Authors: Alexandria Muench; Ivan Vargas; Michael A Grandner; Jason G Ellis; Donn Posner; Célyne H Bastien; Sean Pa Drummond; Michael L Perlis Journal: Fac Rev Date: 2022-02-01
Authors: Emily A Dolsen; Amy L Byers; Annesa Flentje; Joseph L Goulet; Guneet K Jasuja; Kristine E Lynch; Shira Maguen; Thomas C Neylan Journal: Neurobiol Stress Date: 2022-09-15